News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Whoa!!! FAGI is still a low float?
The number of shares outstanding of our Common Stock was:
123,949,611 as of March 31, 2025
Up 100% today. May look back & view this as small compared to where I think it’s going! Revenue going up, could turn profitable in 2025.
https://marketwirenews.com/news-releases/full-alliance-group-otc-fagi-announces-strategic-joi-5166166773068340.html
FAGI.006 MORE BIG NEWS OUT TODAY.Full Alliance Group Announces Strategic Joint Venture with FV Products International to Expand Direct-to-Consumer Nutraceutical and Cosmeceutical Sales
ACCESSWIRE | 04/30/2025
Full Alliance Group Announces Strategic Joint Venture with FV Products International to Expand Direct-to-Consumer Nutraceutical and Cosmeceutical Sales
TAMPA, FL / ACCESS Newswire / April 30, 2025 / Full Alliance Group, Inc. (OTC Pink:FAGI) today announced a transformative joint venture with FV Products International, LLC, a leading eCommerce and digital marketing firm headed by industry experts Valerio Fortunato and Farhia Ibrahim. The joint venture was created to rapidly expand FAGI's direct-to-consumer sales channels in the nutraceutical and cosmeceutical markets.
Under the terms of the agreement, FV Products International was formed as a fifty-one percent owned subsidiary of Full Alliance Group, with Farhia Ibrahim and Valerio Fortunato serving as Management to spearhead digital growth initiatives, including the production of Video Sales Letters, media buying and managing affiliate networks. The collaboration leverages FV Products' digital expertise alongside Pure Solutions' established manufacturing and fulfillment infrastructure to create a comprehensive direct-to-consumer platform.
Valerio Fortunato and Farhia Ibrahim: Global Leaders in eCommerce and Digital Growth
With over two decades of experience in digital marketing, affiliate marketing, and eCommerce operations, Valerio Fortunato is a highly respected leader in the direct-to-consumer space. His expertise spans brand scaling, digital advertising, supply chain logistics, and high-performance sales funnels, making him a sought-after strategist for multinational corporations and fast-growing startups alike.
As a global keynote speaker, Fortunato has educated thousands of entrepreneurs and businesses on affiliate marketing, customer acquisition, conversion optimization, and digital product launches. His career includes successful multi-million-dollar product launches, strategic partnerships with leading global brands, and pioneering data-driven affiliate networks that have redefined how businesses connect with consumers in the digital age.
In his new role leading FV Products, Fortunato will develop and scale high-converting brands in the nutraceutical and cosmeceutical sectors, tapping into emerging consumer demand for premium health and wellness solutions.
"With the infrastructure of Pure Solutions, Inc., this joint venture strategically positions the company for sustained organic growth," said Valerio Fortunato. "The affiliate marketing industry is evolving rapidly, and we see an unprecedented opportunity to align top-tier affiliates with cutting-edge products. Our goal in 2025 is to launch three organic brands that will not only drive significant revenue but also expand Pure Solutions' existing customer base, creating long-term value for our partners and stakeholders."
The partnership comes at a crucial time in the rapidly evolving health and wellness market, where digital presence and direct-to-consumer relationships are increasingly vital. FV Products International brings decades of expertise in affiliate marketing and digital commerce.
Farhia Ibrahim is recognized as one of the leading networkers in the eCommerce industry, known for her deep-rooted connections and influence across the direct response and affiliate marketing space. Over the years, she has cultivated strategic partnerships with top-tier publisher networks and performance marketers, making her a trusted connector and dealmaker. Her ability to bridge brands with high-converting traffic sources has consistently driven growth and profitability for her partners. Farhia's extensive network and keen understanding of the digital landscape position her as a key player in the world of online commerce.
Bill Heneghan, President of Full Alliance Group, Inc., emphasized the strategic importance of the venture: "FV Products brings deep expertise and technical knowledge in today's fast-paced digital landscape. Their proven track record of success in the eCommerce industry makes them an ideal partner. Valerio's leadership and skills will be instrumental in driving unparalleled growth for the company."
The joint venture will focus on several key initiatives:
Development and launch of three new organic brands in 2025
Integration of advanced affiliate marketing strategies
Optimization of digital customer acquisition channels
Creation of award-winning Video Sales Letters ("VSLs")
Enhancement of drop-shipping and fulfillment capabilities
Expansion of Pure Solutions' existing product portfolio
This strategic alliance positions Full Alliance Group to capitalize on the growing demand for health and wellness products through digital channels. The company expects to see significant revenue growth through enhanced direct-to-consumer sales, improved customer acquisition strategies, and expanded market reach.
The collaboration will utilize Pure Solutions' FDA-registered manufacturing facilities and established quality control processes, ensuring that all products meet the highest standards of quality and compliance. This infrastructure, combined with FV Products' digital expertise, creates a robust foundation for sustainable growth in the nutraceutical and cosmeceutical markets.
Media Contact:
Full Alliance Group Inc. Investor Relations
Gabe Rodriguez, Erelations Group
erelationsgroup@gmail.com
(623) 261-9046
FV Products International, LLC
Valerio Fortunato
val@puresolutionsusa.com
(800) 895-4415
About Full Alliance Group, Inc.
Full Alliance Group, Inc. (OTC: FAGI) is a multi-faceted holding company with various subsidiaries and investments in diverse sectors. Through its wholly-owned subsidiary, Pure Solutions, Inc., the company manufactures and distributes premium nutraceutical and cosmeceutical products.
About FV Products International, LLC
FV Products International, LLC is a leading digital marketing and eCommerce solutions provider, specializing in affiliate marketing and direct-to-consumer strategies. Led by Valerio Fortunato and Farhia Ibrahim, the company has established itself as an industry leader in digital commerce and marketing innovation.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected.
SOURCE: Full Alliance Group, Inc.
Eat my shares 💩💩💩
Maybe you should keep your heavy early investors in the loop. I’m probably in the top 5 largest investors in bhgi
Fagi
|
Followers
|
137
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
26199
|
|
Created
|
01/03/11
|
Type
|
Free
|
| Moderators | |||
FAGI SECURITY DETAILS
Share Structure:
Authorized: 500M
Outstanding: 55,843,301 (as of Jan 30 2019)
Restricted 27,006,442
Free trading/Float: 28,836,859.
PALM DESERT, CA / ACCESSWIRE / March 6, 2019 / Full Alliance Group, Inc. (OTC PINK: FAGI) ("Full Alliance Group" or the "Company"), is pleased to announce the appointment of Rick A. Low, MD, FACS, to its Medical Advisory Board.
Born in Honolulu, Hawaii, Dr. Low is a Fellow of the American College of Surgeons with over 25 years experience. Following his 1994 graduation from Johns Hopkins University School of Medicine in Baltimore, Maryland, Dr. Low interned at Cedar-Sinai Medical Center in Los Angeles, California, where became a resident surgeon and eventually Chief Surgical Resident. From 1999 to 2017, he practiced at Valley Surgical Clinics in Phoenix, Arizona. He is currently practicing still in the Phoenix area at Desert Surgical Specialists, a general surgery practice with a focus on general, laparoscopic, and robotic surgery.
Dr. Low is affiliated with Honor Health, North Mountain campus (1999 - current) where he is Chairman, Network Robotic Surgery (2013-current) and Surgeon Champion NSQIP (2016 - current), Honor Health, Deer Valley campus (2008 - current) where he was Chairman, Department of Surgery (2011 - 2016), Paradise Valley Hospital (1999 - current) where he was Chairman, Department of Surgery (2008-2009), Honor Health, Thompson Peak campus (2007 - current), and Honor Health, Shea campus (1999 - current).
Dr. Low has also a highly regarded instructor and guest speaker having trained hundreds of surgeons nationwide in laparoscopic and robotic surgeries including cholecystectomy, colon resection, and hernia repair, and lectured at numerous professional events and conferences. Dr. Low's research has been published in The Annals of Thoracic Surgery, Head & Neck, and Journal of Robotic Surgery.
Dr. Paul Brian Volpp, CEO and President of Full Alliance Group, commented, "We are excited to have Dr. Low join our Medical Advisory Board along with current members Drs. Durrani, Collins, and Purita. Their combined expertise should provide us with an immediate competitive advantage and help to establish Full Alliance Group and its subsidiaries as leading providers in healthcare and medical services."
Sincerely,
Dr. Paul Brian Volpp
President & CEO / Director
Full Alliance Group Inc.
LOS ANGELES, Feb. 28, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Full Alliance Group, Inc. (OTCPK: FAGI) ("Full Alliance Group" or the "Company"), is pleased to announce the formation of its Medical Advisory Board.
Dr. Paul Brian Volpp, CEO and President of Full Alliance Group, commented, "We expect the next several months to be extremely exciting and productive for Full Alliance Group as we move to rapidly accelerate our operations in the healthcare and medical sectors. The formation of a Medical Advisory Board will provide us with access to additional experienced professionals and proven leaders that can offer invaluable guidance to the Company and its subsidiaries as we continue to execute our business plans."
First to join Full Alliance Group's Advisory Board are three American medical professionals; Dr. Samedyar (Sam) Durrani, Dr. Catherine Collins, and Dr. Joseph R. Purita.
Samedyar (Sam) Durrani, MD, born and raised in the Midwest, is a proud graduate of The Ohio State University and The University of Cincinnati College of Medicine. He completed his residency training in general surgery at Mount Carmel Medical Center in Columbus, Ohio. Currently based in the Phoenix, Arizona area since 2010, he established Desert Surgical Specialists, a general surgery practice with a special focus in pancreatic surgery, endocrine surgery, oncologic surgery, and advanced techniques in hernia repair. Dr. Durrani also provides trauma surgery coverage for various hospitals in his area. Dr. Durrani has hospital privileges at Scottsdale Osborn Medical Center, Scottsdale Shea Medical Center, Scottsdale Thompson Peak Medical Center, Deer Valley Medical Center, and John C Lincoln Medical Center. He is certified by the American Board of Surgery.
Christine Collins, MD, is board certified by the American Board of Obstetrics and Gynecology and is a member of the American College of Obstetrics and Gynecology. A graduate of the USC School of Medicine, Beverly Hills gynecologist Christine Collins has been an attending physician at Cedars-Sinai Medical Center for over 20 years, where she also completed her residency training. Dr. Collins was awarded the prestigious ARCS scholarship while in medical school and also merited status as a Dean's Scholar upon graduation. Though she is a traditional GYN, she values the holistic side of medicine and proudly offers this underappreciated route of treatment to the valued patients of her private practice. Dr. Collins is also board certified in anti-aging and regenerative medicine.
Joseph Purita, MD, a regenerative medicine pioneer in the use of stem cell and PRP therapy for orthopedic conditions, graduated from Georgetown University Medical School and served his surgical internship at the University of Florida Medical Center. Following completion of his orthopedic surgery residency at University of Miami-Jackson Memorial Hospital, where he served as the Chief Administrative Resident, Dr. Purita joined the Boca Raton Orthopedic Group in 1981. Dr. Purita is a founding member of the American Academy of Regenerative Medicine and is certified by several organizations, including the American Board of Orthopedic Surgery, American College of Orthopaedic Surgery, American Board of Pain Management, and American Board of Regenerative Medicine. In 2014, Dr. Purita was named one of U.S. News & World Report's "Top Doctors" by the physicians at Doximity, a U.S. healthcare professional network with over 1 million members.
Dr. Volpp concluded, "We are honored to have Drs. Durrani, Collins, and Purita as the first members of the Full Alliance Group Medical Advisory Board. Their extensive knowledge of medicine, patient care, and healthcare business operations will be a great benefit to the Company and its shareholders going forward."
Full Alliance Group anticipates appointing additional members to the Medical Advisory Board over the next several weeks which should further enhance management's ability to direct the future growth of the Company.
Sincerely,LOS ANGELES, Feb. 26, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Full Alliance Group, Inc. (OTCPK: FAGI) ("Full Alliance Group" or the "Company"), is pleased to announce that Dr. Paul Brian Volpp has succeeded Jacob Thomas as CEO and President of Full Alliance Group upon Thomas's retirement. In addition, Mr. Rudy Kiste, currently the Company's Chief Financial Officer, will join the Full Alliance Group board of directors.
"We would like to sincerely thank Jacob Thomas for his years of leadership and service to Full Alliance Group as CEO, President, and Chairman of the Board. We wish him the best in retirement," stated newly appointed CEO and President, Dr. Paul Brian Volpp. "In taking the helm at Full Alliance Group, I am confident that my medical education, training, and hands-on experience at providing patient care in my own practice and in large hospital settings will enable me to lead the Company's expansion in healthcare and nutraceuticals."
P. Brian Volpp, M.D., MPH completed undergraduate work at Princeton University where he graduated cum laude with a degree in history and a certificate in American Studies. He subsequently completed a dual M.D./MPH program, studying medicine in his adopted home state of Nevada and public health administration at Loma Linda University, where he was selected to the Delta Omega Honor Society.
He completed his residency in Los Angeles, first in preliminary medicine at Cedars-Sinai Medical Center followed by radiation oncology training at Kaiser Permanente. Dr. Volpp is board certified in both radiation oncology and integrative medicine, and practices at Palomar Hospital in Escondido as well as all three Sharp hospitals in greater San Diego. He is currently medical director of radiation therapy at Palomar as well as medical director for San Diego Radiosurgery.
During his career, Dr. Volpp published peer-reviewed research on spinal cord tumors and prostate cancer. Special interests include radiosurgery, integrative and complementary cancer medicine as well as palliative care/pain management.
Dr. Volpp concluded, "Over the next several weeks, we anticipate adding several additional senior team members and advisors to the Full Alliance Group team. I look forward to working with our growing teams to execute our refocused business strategy."
LOS ANGELES, CA / ACCESSWIRE / February 19, 2019 / Full Alliance Group, Inc. (OTC PINK: FAGI) (''Full Alliance Group'' or the ''Company''), today announced it has entered into a definitive Stock Acquisition Agreement with Dr. Louie Yu, sole shareholder of proprietary nutraceutical developer Nutra Yu, Inc. (''Nutra Yu'') and innovative blood therapy company EBO2, Inc. (''EBO2''), pursuant to which both Nutra Yu and EBO2 have become wholly-owned subsidiaries of Full Alliance Group.
Pursuant to the Stock Acquisition Agreement, Full Alliance Group acquired all the outstanding shares of both Nutra Yu and EBO2 in exchange for the issuance of 5,000,000 ''restricted'' shares of FAGI common stock and 25,000,000 shares of Series B Preferred Stock.
In connection with the closing of the acquisitions, Dr. Louie Yu was appointed Chief Medical Officer of Full Alliance Group. With nearly 25 years of specialized education, training, and patient practice, Dr. Yu is an international medical consultant, Doctor of Traditional Chinese Medicine (TCM) and Doctor of Chiropractic specializing in orthomolecular medicine. Dr. Yu is considered a pioneer in oxidative medicine, which is still in its infancy. He was the protégé of the late Dr. Alfred Libby, one of the fathers of Orthomolecular medicine, homeopathy, and nutraceutical formulation. In 2012 Dr. Yu's multi systems approach to medicine were proven via a clinical trial conducted at the World Clinical Trials Center, which was a collaboration between Dr. Yu's Methods and the Biologique center for Regenerative Medicine. Known worldwide as the creator of Quantum Energetic Medicine, he has been able to bridge the gap between modern medicine, and the curative wisdom of the East. Additional management changes and additions are expected in the near future that will further establish the Company within the nutraceutical and healthcare sector.
Dr. Paul Brian Volpp, Director of Full Alliance Group, commented, ''We are very pleased to have successfully launched Full Alliance into the rapidly expanding medical healthcare and nutraceutical industries with the acquisition of Nutra Yu and EBO2. Under the guidance of their founder, renowned doctor and nutraceutical and alternative medicine expert, Dr. Louie Yu, with his long list of proprietary formulations nutritional therapy protocols, we plan to quickly and strategically expand Nutra Yu and EBO2 brands, services, and locations with new distribution channels in markets around the globe. We look forward to assisting Dr. Yu and his team to build Nutra Yu and EBO2 into globally recognized and trusted names in healthcare and nutraceuticals.''
Dr. Louie Yu, Chief Medical Officer of Full Alliance Group and founder of Nutra Yu and EBO2, commented, ''These two companies have access to the entirety of training, knowledge, and research that I have conducted over my lifetime and career in search of effective cutting-edge medicines, remedies, and regenerative treatments. Over the next few months, we plan to dramatically ramp up distribution and marketing for our Nutra Yu product line, direct new clinical studies, and potentially open the first EBO2 clinics in several states in the U.S. With new regulations and legal protections recently enacted in many U.S. states, we are confident that we are entering a very exciting period of growth, expansion, and acceptance for complementary and alternative medicine in America. Nutra Yu, EBO2, and Full Alliance Group are well-positioned to take full advantage of this growing long-term trend.''
Sincerely,
Jacob Thomas
CEO, Chairman of the Board
About Nutra Yu, Inc.
Nutra Yu, Inc. was founded by Dr. Yu to further develop, market, and distribute his proprietary line of nutraceuticals. Nutra Yu's ''Dr. Louie Yu Formulations'' are a complete product line of unique all-natural nutraceuticals based on the science of traditional Chinese medicine, Western orthomolecular concepts, and modern-day physics. This innovative fusion of eastern and western methodologies has generated a remarkable new scientific system which management believes effectively addresses the root of most daily health conditions - inflammation, weight gain, the loss of vital energy, and environmental toxicity.
The Dr. Louie Yu Formulations brand currently consists of more than ten (10) distinct products, including multivitamins and minerals, amino acid blends, immune boosters, digestion aids, sleep aids, stress relief, and hormone support. Dr. Yu's orthomolecular formulation of ingredients are not found in any other supplement product and contain no starch, corn, milk, wheat, yeast, sugar, caffeine, eggs, salt, artificial colors, binders, flavors, preservative or fish derivatives. Dr. Louie Yu Formulations are sold direct to consumers via various Dr. Yu clinics/practices and recently online through Amazon.com.
For additional information regarding Nutra Yu, visit www.drlouieyu.com
About EBO2, Inc.
EBO2, Inc. is the provider of ''EBO2'', a second-generation blood treatment technology developed by Dr. Yu over the past 20 years which management believes is 100x faster and more efficient than traditional outdated autohemotherapy and 10 pass techniques. Combined with exclusive pre- and post-treatment nutraceuticals developed exclusively by Dr. Yu, the EBO2 procedure is the world's most advanced medical ozone treatment performed today.
The EBO2 procedure is a minimally invasive intravenous therapy similar to hemodialysis developed as a treatment for many cardiological problems, allowing the patient to avoid life threatening, highly risky, painful, expensive and complicated surgeries and long recovery periods. In this procedure, EBO2 re-circulates all a patient's blood (5-7 liters) over a period of 60-90 minutes for treatment with medical ozone to remove extra inactive proteins which lead to autoimmune related disorders, separate fats, cholesterol, heavy metal toxins, and diseased dead cells and then traps and removes impurities and fats in special patented filtration system.
Medical ozone therapy is already a well-established alternative and complementary therapy in most major European countries, including Germany, France, Italy, Austria and Switzerland. Other countries are also active in ozone therapy, including Russia, Greece, Israel, Japan, Malaysia, Mexico, Brazil, Columbia, Argentina, Dominion Republic and Cuba. In the United States, Complementary and Alternative Medicine (CAM) legislation has now made medical ozone therapy an option for some patients in thirteen states, including Alaska, Arizona, Colorado, Connecticut, Georgia, Minnesota, Nevada, New Mexico, New York, Ohio, Oregon and Washington. EBO2 intends to provide treatments in the United States from company owned and operated clinics in CAM friendly states.
For additional information regarding EBO2, visit www.fullalliance.com
Full Alliance Group management and board of directors anticipate making decisive assessments regarding the direction of the previously announced fintech acquisitions of MY PAY, Kelevra Digital Solutions, and GBE Grupo Empresarial de Tamaulipas SAPI. Additionally, Full Alliance Group would like to announce the termination of the previously announced Purchase Agreement to acquire a New York-based investment banking firm as the selling parties requested the unacceptable removal of a previously agreed upon binding ''No Share Consolidation'' clause required to protect the interests of current shareholders.
Contact: ir@fullalliance.com
Passage- More Info
Soma Plex- More Info
Balance- More Info
CEE Minerals- More Info
Endocrine Plus- More Info
In treating almost every type of disease known to man, there has been one constant, nutritional therapy and diet has always played a key role to disease and dysfunction. This is a key difference to my understanding of treatment and formulations which differs from the vast majority.
The last few years have been dedicated to chiropractic, orthomolecular medicine and EBOO ozone technologies. What is interesting is that all the assumptions made about the health status of the human body through advanced diagnostic testing is that of the blood, is that blood observed in the EBOO protocols much different than previously known. EBOO stands for Extracorporeal Blood Oxygenation and Ozination. EBOO is the worlds most advanced and critical medical ozone treatment performed today. With my development with EBOO we can see that the fats that are the leading cause of cardiovascular disease occurs much earlier than previously predicted or known, which increase the risk factors for cardiovascular events such as heart attacks, transient ischemic attacks and strokes by almost 200%
Based on my research and understanding the new line of nutraceuticals are all formulated with the understanding that the blood and the body are reacting much different than what is known today. This premise is based on the fact that we see more fats and toxins in the blood while performing the EBOO protocols. To take a healthy male or female with a good medical history, good diet history, and good nutritional supplement program and see that when performing the EBOO procedure, that the blood is laden with fats, plaques, heavy metals, and toxins.
You take sick people with specific diseases and make them well; you take healthy people and make them better all the while seeing drastic changes in their appearances. This is the newest form of anti-aging medicine and the best treatment of most heart conditions eliminating the need for surgery. This all done by EBOO technologies.
The nutraceuticals that I formulate, manufacture and distribute are unique in the market place. They are formulated with three things in mind.
Delivery system. The products are designed to pass into the blood stream using different mechanisms of delivery in the body. Most nutritional products do not take into consideration the disease state of the patient. The ability to assimilate the products and what happens to the products as they enter the system. How does the product go through gastrointestinal assimilation and what are the pitfalls to normal digestion and metabolism of the pills, capsules, tablets and liquids. As well as how they are in turn used by the system. Each product has a unique site of metabolism if attached to a specific delivery system. Delivery is paramount when you talk about nutrition and supplements. If you are only counting on the fact that you put a pill into your mouth or drink a magic potion to heal yourself then you are sadly mistaken. You must have a delivery system in place to insure your body will maximize absorption and utilization of the products.
Stability. How are the products stabilized? What mechanism are used to ensure product stability not only in the product form but as well how they remain stable in the body after consumption and utilization. I am concerned with the different types of preservatives and chemical stabilizers that keep the product intact for their intended use, keeping to more natural forms that mimic what occurs in nature. Fat content, solubility, temperature in various organs etc.
Synergy. I have developed what I call synergistic strategies for formulation. I check not only the chemical compatibility of the ingredients but the energetic compatibility as well. This is a unique and proprietary process only known to me. That thought process and energetic testing are solely an invention to me and no one else in the world.
Clinical observation. Products are used on my patients in my office based on their specific disease state. With that in mind, when products are in the beta phase of testing, I have patients with specific problems in physiology and try them to see if they are effacious. The idea being if these patients can absorb, metabolize and utilize the products well, then the average person in reasonable health will do so much more efficiently. This is the reason why my nutritional supplements and EBOO protocols are called “First Choice for a Second Chance.” Most of my patients have been through the gambit of doctors and treatments and have been failed medically or by alternative complimentary therapies. They come to me out of hope and desperation to find a way to better health.
Because I take these factors into account, the products are unique to my clinical practice. All formulations are made out of necessity for the patient’s health benefit. As I work as an active clinician, I see trends in health and disease, therefore I stay ahead of the game by introducing products based on treatment needs since food and nutrition are the keys to maintaining good health and well-being.
Dr. Louie Yu
EBO2, Inc. is the provider of “EBO2”, a second-generation blood treatment technology developed by Dr. Yu over the past 20 years which is 100x faster and more efficient than traditional outdated autohemotherapy and 10 pass techniques. Combined with exclusive pre- and post-treatment nutraceuticals developed exclusively by Dr. Yu, the EBO2 procedure is the world’s most advanced medical ozone treatment performed today.
The EBO2 procedure is a minimally invasive intravenous therapy similar to hemodialysis developed as a treatment for many cardiological problems, allowing the patient to avoid life threatening, highly risky, painful, expensive and complicated surgeries and long recovery periods. In this procedure, EBO2 re-circulates all a patient’s blood (5-7 liters) over a period of 60-90 minutes for treatment with medical ozone to remove extra inactive proteins which lead to autoimmune related disorders, separate fats, cholesterol, heavy metal toxins, and diseased dead cells and then traps and removes impurities and fats in special patented filtration system. EBO2 also helps with reversing auto immune related diseases, inflammatory diseases and arthritis, as well as Lyme disease and it’s related co-infections.
Medical ozone therapy is already a well-established alternative and complementary therapy in most major European countries, including Germany, France, Italy, Austria and Switzerland. Other countries are also active in ozone therapy, including Russia, Greece, Israel, Japan, Malaysia, Mexico, Brazil, Columbia, Argentina, Dominion Republic and Cuba. In the United States, Complementary and Alternative Medicine (CAM) legislation has now made medical ozone therapy an option for some patients in thirteen states, including Alaska, Arizona, Colorado, Connecticut, Georgia, Minnesota, Nevada, New Mexico, New York, Ohio, Oregon and Washington. EBO2 intends to provide treatments in the United States from company owned and operated clinics in CAM friendly states.
AI
